- Home
- HASI vs ACLX Comparison
HASI vs ACLX Comparison
Compare HASI & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HASI | ACLX |
|---|---|---|
| Founded | 1981 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 3.7B |
| IPO Year | 2012 | 2022 |
Fundamental Metrics
Financial Performance| Metric | HASI | ACLX |
|---|---|---|
| Price | $36.39 | $114.01 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 15 |
| Target Price | $42.57 | ★ $115.85 |
| AVG Volume (30 Days) | 1.1M | ★ 3.3M |
| Earning Date | 05-14-2026 | 01-01-0001 |
| Dividend Yield | ★ 4.64% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.41 | N/A |
| Revenue | ★ $400,502,000.00 | $22,286,000.00 |
| Revenue This Year | $378.36 | $480.59 |
| Revenue Next Year | $13.53 | $88.40 |
| P/E Ratio | $25.98 | ★ N/A |
| Revenue Growth | ★ 4.41 | N/A |
| 52 Week Low | $21.98 | $47.86 |
| 52 Week High | $40.01 | $114.26 |
Technical Indicators
Market Signals| Indicator | HASI | ACLX |
|---|---|---|
| Relative Strength Index (RSI) | 51.18 | 83.68 |
| Support Level | $31.82 | $64.61 |
| Resistance Level | $40.01 | $114.26 |
| Average True Range (ATR) | 1.16 | 1.62 |
| MACD | -0.25 | 4.30 |
| Stochastic Oscillator | 23.52 | 99.53 |
Price Performance
Historical ComparisonAbout HASI Hannon Armstrong Sustainable Infrastructure Capital Inc.
HA Sustainable Infrastructure Capital Inc is an investor in sustainable infrastructure assets advancing the energy transition. Its investment is focused on actively partnering with clients to deploy capital in income-generating real assets that are supported by long-term recurring cash flows. This enabled to the generation of attractive risk-adjusted returns and provided stockholders with diversified exposure to the energy transition.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.